William Mann, has been appointed as new CEO in the American subsidiary, Helsinn Therapeutics (U.S.). William Mann, was already COO of the recently acquired Helsinn Therapeutics, and has held leadership positions in a Swiss multinational with positions in Business Development and in Research.
Helsinn also announces that William Brown has been hired as Vice President Commercial Operations U.S. to build a Helsinn Therapeutics direct sales structure in the U.S. Brown has experience in multinational groups and in the management of Supportive Care, having previously managed the product Aloxi in MGI Pharma.